KU Hematology & Medical Oncology Review 2019
KU ASCO 2019 MDS & MPN Update - Luspatercept in Lower-Risk MDS & Ruxolitinib Study + PI3K in Myelofibrosis
Comments 0
Login to view comments.
Click here to Login
